Nancy Puzziferri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nancy Puzziferri has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Bruce M. Wolfe
Oregon Health & Science University, Portland, Oregon (B.M.W.).
2 shared publicationsEdward H. Livingston
Department of Surgery, University of Texas Southwestern Medical Center, Dallas2Department of Surgery, North Texas Veterans Administration Healthcare System, Dallas5Department of Biomedical Engineering, University of Texas-Arlington, Arlington6Deputy Edito
2 shared publicationsRyan Gallagher
Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA
2 shared publicationsA John Rush
From the Departments of Surgery and Clinical Sciences, The University of Texas Southwestern Medical Center, Dallas, Texas
1 shared publication- B. Gisella Carranza-Leon
Department of Internal Medicine, Division of Endocrinology, Vanderbilt University, Nashville, TN, USA
1 shared publication Beverley Adams-Huet
Department of Clinical Sciences
1 shared publication
Latest Publications
- 4 December 2018
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 169 (11) , 806-807
PCORnet Bariatric Surgery Outcomes: Strength in Numbers
- 4 December 2018
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 169 (11) , 806-807
PCORnet Bariatric Surgery Outcomes: Strength in Numbers
- 17 January 2018
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 137, 224-230
Metabolic response 4 years after gastric bypass in a complete cohort with type 2 diabetes mellitus
- 17 January 2018
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 137, 224-230
Metabolic response 4 years after gastric bypass in a complete cohort with type 2 diabetes mellitus
- Open Access
- 1 September 2017
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 10, 393-402
Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
Background: Bariatric surgery is known to decrease weight and the prevalence of comorbidities, but there is little evidence on the differential effect of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) on the remission of the aggregate outcome, metabolic syndrome, 4 years after surgery. The purpose of this study was to determine the effectiveness of RYGB and SG on metabolic syndrome in veterans. Methods: We retrospectively reviewed consecutive patients who underwent SG and RYGB at the Dallas Veterans Affairs Medical Center from 2003 to 2012. We determined the effect of both the operations on the remission of metabolic syndrome, its individual components, and medium-term morbidity and mortality. A sensitivity analysis was performed using propensity matching. Results: A total of 266 patients were identified (159 RYGB and 107 SG) with 96% follow-up after 4 years. The mean age of the cohort was 51.4 years; the majority of patients were male (59%) and Caucasian (69%). RYGB patients had a greater mean body mass index and were more likely to have hypertension or hypertriglyceridemia. RYGB was associated with a similar metabolic syndrome remission to SG (37.6% vs 26.8%; P=0.09). The percentage of weight loss was 26.5% after RYGB and 10.8% after SG at 4 years post operation (PP=0.74), RYGB was associated with a greater rate of morbidity. Conclusion: RYGB and SG seem to be associated with similar remission rates of metabolic syndrome at 4 years. RYGB yields greater weight loss with greater medium-term complications.
- 1 September 2017
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 10, 393-402
Open AccessMetabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
Background: Bariatric surgery is known to decrease weight and the prevalence of comorbidities, but there is little evidence on the differential effect of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) on the remission of the aggregate outcome, metabolic syndrome, 4 years after surgery. The purpose of this study was to determine the effectiveness of RYGB and SG on metabolic syndrome in veterans. Methods: We retrospectively reviewed consecutive patients who underwent SG and RYGB at the Dallas Veterans Affairs Medical Center from 2003 to 2012. We determined the effect of both the operations on the remission of metabolic syndrome, its individual components, and medium-term morbidity and mortality. A sensitivity analysis was performed using propensity matching. Results: A total of 266 patients were identified (159 RYGB and 107 SG) with 96% follow-up after 4 years. The mean age of the cohort was 51.4 years; the majority of patients were male (59%) and Caucasian (69%). RYGB patients had a greater mean body mass index and were more likely to have hypertension or hypertriglyceridemia. RYGB was associated with a similar metabolic syndrome remission to SG (37.6% vs 26.8%; P=0.09). The percentage of weight loss was 26.5% after RYGB and 10.8% after SG at 4 years post operation (PP=0.74), RYGB was associated with a greater rate of morbidity. Conclusion: RYGB and SG seem to be associated with similar remission rates of metabolic syndrome at 4 years. RYGB yields greater weight loss with greater medium-term complications.
- 1 July 2017
- Published by Elsevier in Sleep Medicine
- Vol. 35, 91
Putting weight-loss-cures-all to rest.
- 1 July 2017
- Published by Elsevier in Sleep Medicine
- Vol. 35, 91
Putting weight-loss-cures-all to rest.
- Open Access
Brain imaging demonstrates a reduced neural impact of eating in obesity
Objective: This study investigated functional brain response differences to food in women with BMI either 35 kg/m2 (severe obesity).Design and Methods: Thirty women, 18‐65 years old, from academic medical centers participated. Baseline brain perfusion was measured with arterial spin labeling. Brain activity was measured via blood‐oxygen‐level‐dependent functional magnetic resonance imaging in response to food cues, and appeal to cues was rated. Subjective hunger/fullness was reported pre‐ and post‐imaging. After a standard meal, measures were repeated.Results: When fasting, brain perfusion did not differ significantly between groups; and both groups showed significantly increased activity in the neo‐ and limbic cortices and midbrain compared with baseline (P < 0.05, family‐wise‐error whole‐brain corrected). Once fed, the lean group showed significantly decreased activation in these areas, especially the limbic cortex, whereas the group with severe obesity showed no such decreases (P < 0.05, family‐wise‐error whole‐brain corrected). After eating, appeal ratings of food decreased only in lean women. Within groups, hunger decreased (P < 0.001) and fullness increased (P < 0.001) fasted to fed.Conclusions: While fasting, brain response to food cues in women did not differ significantly despite BMI. After eating, brain activity quickly diminished in lean women but remained elevated in women with severe obesity. These brain activation findings confirm previous studies.
Open AccessBrain imaging demonstrates a reduced neural impact of eating in obesity
Objective: This study investigated functional brain response differences to food in women with BMI either 35 kg/m2 (severe obesity).Design and Methods: Thirty women, 18‐65 years old, from academic medical centers participated. Baseline brain perfusion was measured with arterial spin labeling. Brain activity was measured via blood‐oxygen‐level‐dependent functional magnetic resonance imaging in response to food cues, and appeal to cues was rated. Subjective hunger/fullness was reported pre‐ and post‐imaging. After a standard meal, measures were repeated.Results: When fasting, brain perfusion did not differ significantly between groups; and both groups showed significantly increased activity in the neo‐ and limbic cortices and midbrain compared with baseline (P < 0.05, family‐wise‐error whole‐brain corrected). Once fed, the lean group showed significantly decreased activation in these areas, especially the limbic cortex, whereas the group with severe obesity showed no such decreases (P < 0.05, family‐wise‐error whole‐brain corrected). After eating, appeal ratings of food decreased only in lean women. Within groups, hunger decreased (P < 0.001) and fullness increased (P < 0.001) fasted to fed.Conclusions: While fasting, brain response to food cues in women did not differ significantly despite BMI. After eating, brain activity quickly diminished in lean women but remained elevated in women with severe obesity. These brain activation findings confirm previous studies.
- Top Cited PapersOpen Access
- 3 September 2014
- Published by American Medical Association (AMA) in JAMA
- Vol. 312 (9) , 934-942
Long-term Follow-up After Bariatric Surgery
Although bariatric surgery is commonly performed, it is not universally accepted as an obesity treatment. In 2009, a Cochrane systematic review advised caution before accepting the effectiveness of bariatric surgery because of limited high-quality evidence supporting its use.1 Most published studies of bariatric surgery are retrospective, short-term studies with insufficient follow-up.2 Substantial missing data in these studies preclude definitive conclusions about the procedures’ outcomes. Although there is ample short-term evidence about the benefits and risks of bariatric surgery up to 1 year after surgery, few data are available about long-term outcomes or groups.
- 3 September 2014
- Published by American Medical Association (AMA) in JAMA
- Vol. 312 (9) , 934-942
Top Cited PapersOpen AccessLong-term Follow-up After Bariatric Surgery
Although bariatric surgery is commonly performed, it is not universally accepted as an obesity treatment. In 2009, a Cochrane systematic review advised caution before accepting the effectiveness of bariatric surgery because of limited high-quality evidence supporting its use.1 Most published studies of bariatric surgery are retrospective, short-term studies with insufficient follow-up.2 Substantial missing data in these studies preclude definitive conclusions about the procedures’ outcomes. Although there is ample short-term evidence about the benefits and risks of bariatric surgery up to 1 year after surgery, few data are available about long-term outcomes or groups.
- 1 August 2008
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 248 (2) , 233-242
Variations of Weight Loss Following Gastric Bypass and Gastric Band
Objective: To compare and describe the weight loss outcomes from gastric bypass and gastric band so as to define the variation of excess weight loss (EWL) among individual patients, the time to onset of effect, and the durability of weight loss in severely obese adults. Summary Background Data: Gastric bypass and gastric band are the most common operations for obesity performed in the United States, but few reports have compared these 2 procedures. Methods: Patients (N = 1733, aged 18–65 years) met National Institutes of Health criteria for obesity surgery and underwent either gastric bypass or gastric band between March 1997 and November 2006. The selection of bypass versus band was based on patient/ surgeon discussion. The evaluable sample consisted of 1518 patients. The percentage of EWL was assessed over 2 years. Successful weight loss was defined a priori as ≥40% EWL in each of four 6-month postoperative measurement periods. The analyses included a mixed model and generalized estimating equation (GEE) model with repeated measures. Odds ratios and descriptive analyses were also provided. Results: Gastric bypass was associated with less individual variation in weight loss than gastric band. Both procedures were associated with a significant EWL benefit (Treatment Group effect P < 0.0001), but they differed in terms of time to effect (Treatment Group × Period interaction effect P < 0.0001). The mean EWL for gastric bypass was greater at each measurement period (6, 12, 18, 24 months) compared with gastric band (P < 0.0001). Furthermore, at each of the postoperative measurement periods within each treatment group (bypass and band), the mean EWL was greater for those who had preoperative body mass index (BMI) ≤50 kg/m2 than for those who had preoperative BMI >50 kg/m2 (P < 0.0001). Gastric bypass was consistently associated with a greater likelihood of at least a 40% EWL in each of the 6-month postoperative measurement periods (GEE, P < 0.0001). The odds ratio estimates at months 6, 12, 18, and 24 were 18.2, 20.6, 15.5, and 9.1, respectively. Despite these clinically meaningful outcome differences, nearly all (≥93%) bypass and band patients who had ≥40% EWL at 6, 12, or 18 months postoperatively maintained at least this level of success at 2 years. Conclusions: Gastric bypass produced more rapid, greater, and more consistent EWL across individuals over a 2-year postoperative period than gastric band.
- 1 August 2008
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 248 (2) , 233-242
Variations of Weight Loss Following Gastric Bypass and Gastric Band
Objective: To compare and describe the weight loss outcomes from gastric bypass and gastric band so as to define the variation of excess weight loss (EWL) among individual patients, the time to onset of effect, and the durability of weight loss in severely obese adults. Summary Background Data: Gastric bypass and gastric band are the most common operations for obesity performed in the United States, but few reports have compared these 2 procedures. Methods: Patients (N = 1733, aged 18–65 years) met National Institutes of Health criteria for obesity surgery and underwent either gastric bypass or gastric band between March 1997 and November 2006. The selection of bypass versus band was based on patient/ surgeon discussion. The evaluable sample consisted of 1518 patients. The percentage of EWL was assessed over 2 years. Successful weight loss was defined a priori as ≥40% EWL in each of four 6-month postoperative measurement periods. The analyses included a mixed model and generalized estimating equation (GEE) model with repeated measures. Odds ratios and descriptive analyses were also provided. Results: Gastric bypass was associated with less individual variation in weight loss than gastric band. Both procedures were associated with a significant EWL benefit (Treatment Group effect P < 0.0001), but they differed in terms of time to effect (Treatment Group × Period interaction effect P < 0.0001). The mean EWL for gastric bypass was greater at each measurement period (6, 12, 18, 24 months) compared with gastric band (P < 0.0001). Furthermore, at each of the postoperative measurement periods within each treatment group (bypass and band), the mean EWL was greater for those who had preoperative body mass index (BMI) ≤50 kg/m2 than for those who had preoperative BMI >50 kg/m2 (P < 0.0001). Gastric bypass was consistently associated with a greater likelihood of at least a 40% EWL in each of the 6-month postoperative measurement periods (GEE, P < 0.0001). The odds ratio estimates at months 6, 12, 18, and 24 were 18.2, 20.6, 15.5, and 9.1, respectively. Despite these clinically meaningful outcome differences, nearly all (≥93%) bypass and band patients who had ≥40% EWL at 6, 12, or 18 months postoperatively maintained at least this level of success at 2 years. Conclusions: Gastric bypass produced more rapid, greater, and more consistent EWL across individuals over a 2-year postoperative period than gastric band.
- 1 January 2006
- Published by Springer Nature in Endocrine
- Vol. 29 (1) , 11-20
Surgical Treatment of Obesity
The surgical treatment of obesity has existed for over 50 yr. Surgical options have evolved from high-risk procedures infrequently performed, to safe, effective procedures increasingly performed. The operations used today provide significant durable weight loss, resolution or marked improvement of obesity-related comorbidities, and enhanced quality of life for the majority of patients. The effect of bariatric surgery on the neurohormonal regulation of energy homeostasis is not fully understood. Despite its effectiveness, less than 1% of obese patients are treated surgically. The perception that obesity surgery is unsafe remains a deterrent to care.
- 1 January 2006
- Published by Springer Nature in Endocrine
- Vol. 29 (1) , 11-20
Surgical Treatment of Obesity
The surgical treatment of obesity has existed for over 50 yr. Surgical options have evolved from high-risk procedures infrequently performed, to safe, effective procedures increasingly performed. The operations used today provide significant durable weight loss, resolution or marked improvement of obesity-related comorbidities, and enhanced quality of life for the majority of patients. The effect of bariatric surgery on the neurohormonal regulation of energy homeostasis is not fully understood. Despite its effectiveness, less than 1% of obese patients are treated surgically. The perception that obesity surgery is unsafe remains a deterrent to care.
- 31 August 2005
- Published by Elsevier in Surgical Clinics of North America
- Vol. 85 (4) , 741-755
Psychologic Issues in Bariatric Surgery—the Surgeon's Perspective
- 31 August 2005
- Published by Elsevier in Surgical Clinics of North America
- Vol. 85 (4) , 741-755
Psychologic Issues in Bariatric Surgery—the Surgeon's Perspective